Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
YES I FOLLOW DR JOEY.....
ESPECIALLY THE PART AROUND THE 46 MIN MARK WHERE HE TRYS TO DECIPHER WHAT DR J MEANT
WITH HIS PATENT POST ON NRX WEBSITE!!! DR JOEY TRIES TO “CORRECT” WHAT HE BELIEVES DR J
MEANT TO WRITE IN THE POST.. DONT GET IT TWISTED DR J WROTE EXACTLY WHAT HE WANTED TO
WRITE AND USED THE EXACT VERBIAGE HE WANTED TO USE (aviptadil)!! SO EVEN DR JOEY
STATES THAT HE HAS NO IDEA WHY DR J WOULD HAVE POSTED THIS... “THERE ARE ALOT OF ISSUES
OF CONCERN WITH HOW THAT (dr javitts patent post) IS WORDED” - Dr Joey
IN SPEAK ABOUT DR JAVITS CEO PATENT MESSAGE “THIS IS WRONG, ON SEVERAL DIFFERENT LEVELS, THE WAY THIS IS WORDED” ..... Dr JAVITT NEW EXACTLY WHAT HE WAS SAYING AND WRITING, YOU THINK THE CEO OF THIS COMPANY, THE ONE YOU ALL HAVE SAID IS THE “MASTER” THE DREAM TEAM, TOP 1% OF QUOTED SCIENTISTS WOULD MAKE A MISTAKE IN WHAT HE IS WRITING AT THIS LEVEL??? THE ANSWER IS ABSOLUTELY NOT!!!
I PERSONALLY FIND IT EXTREMELY CONCERNING AND ALSO MORE CONCERNING THAT THE ABSENT
ABYSMAL RELIEF MANAGEMENT TEAM HAS DONE THEIR USUAL, NOTHING!!!!!
DO WE THINK NRX WILL ADVISE HOW MUCH MONEY THEY SPENT/ARE CURRENTLY SPENDING ON MANUFACTURING OF OUR DRUG AVIPTADIL FOR “IMMINENT“ EUA APPROVAL????
WOULD BE NICE TO HEAR WHAT RELIEF HAS SPENT ALSO BUT RAM, JACK, AND THE REST OF THE INEPT MANAGEMENT AT RELIEF WOULD NEVER ACTUALLY BE HONEST AND TRANSPARENT
*** WHY WERE TWO ARMS OF ACTIV TRIAL REMOVED?****
LACK OF TRANSPARENCY!!!!!
FUNNY PEOPLE SAY “PATENT IS OLD NEWS”
OLD NEWS HUH... THEN WHY DID DR JAVITT ALL OF A SUDDEN POST IT ON HIS COMPANIES PAGE....
A PAGE HE KNOWS WILL PROBABLY GET A LOT OF TRAFFIC AFTER RINGING NASDAQ BELL....
PEOPLE WONDER WHY ITS CALLED PUMP AND DUMP OR WHY MANAGEMENT IS UNTRUSTWORTHY TOP TO BOTTOM...
AMAZING HOW MANY TIMES WE HEARD ABOUT PRODUCTION LEVELS BEING 100,000 DOSES OR 1 MILLION IN FREEZER... OR 30,000 PER... OR ETC.. TO PUMP INVESTORS... BUT THEY ARE NOT HONEST OR TRANSPARENT WHEN THEY REALIZE THAT STABILITY WAS ONLY 9 DAYS.. WHY NOT ASVISE SHAREHOLDERS OF THAT? WHY ONLY THE POSITIVE “PUMP” THEN LEAD US TO BELIEVE THAT WHOLE TIME (AND NEW INVESTORS LED TO BELIEVE NO ISSUE) ONLY TO ADVISE RECENTLY THAT THERE WAS FORMULATION ISSUE THE WHOLE TIME AND THAT ONLY NOW ITS FIXED!!!
OH YEAH AND NOW RELIEF PATENT DOESNT COVER THIS NEW FORMULATION....
DAY 73 OF “THE REGULATORY AGENCY ALREADY KNOWS A LOT ABOUT OUR DRUG AND (DR JAVITT) EXPECTS A PROMPT RESPONSE”
ANY WAY WE CAN BET ON DR DELAY ANNOUNCING THAT, YET ANOTHER DELAY DURING THE CLINICAL UPDATE PORTION OF THE CONFERENCE CALL?? TWO THINGS FOR SURE WITH THIS.....
#1 THEY APPEAR TO CARE LESS ABOUT DELAYS (EXCEPT IF ITS RELATED TO MERGER/COMPENSATION)
#2 GREED AND PROFITS FOR THEN APPEAR TO OUTWEIGH THE SICK AND SUFFERING
LET ME SAY THIS FOR THE 1000 TIME
I AM NOT A SHORT (never shorted a stock in my life)
I AFFIRM HERE IN WRITING THAT I AM A SHAREHOLDER WITH A SUBSTANTIAL POSITION AND HAVE
BEEN INVESTED WELL OVER A YEAR..
I AM ALSO NOT A PAID BASHER I AM JUST A FURIOUS SHAREHOLDER TIRED OF BEING LIED TO AND
MISLED BY GREEDY SLIME MANAGEMENT!!!!
IF RLF FAILS RELIEF FAILS, PERIOD!!!!
FOR THOSE THAT ASK “WOULD THEY REALLY RISK IT OVER 4,000,000.... THE ANSWER IS RIGHT IN
FRONT OF YOU.... THEY HAVE!! THEY ABSOLUTELY HAVE!!!! THEY NOW SAY THEY “BELIEVE” THEY
HAVENT VIOLATED THE AGREEMENT AND THEY “BELIEVE” THEY ARE RIGHT!! THEY EVEN ARE NOT
SURE... SO IF YOU ARE UNABLE TO SAY UNEQUIVOCALLY THAT YOU KNOW THE OUTCOME, YET YOU
STILL BET WITH THE POSSIBILITY OF LOSING, THATS GAMBLING, FACTS!! AND THEY ARE GAMBLING!
ALL THE OTHER SMOKE AND MIRROR TRASH THEY TRY AND SHOVE DOWN OUR THROATS IS
ABSOLUTELY NOTHING WITHOUT APPROVAL OF AVIPTADIL!!! EVER WONDER WHY EVERYWHERE, ALL
OVER WHAT LITTLE PR’s THEY ACTUALLY PUT OUT OF ANY SUBSTANCE ITS SAYS “OUR MAIN
COMPOUND, RLF....”. THEY EVEN KNOW ITS RLF/AVIPTADIL OR NOTHING.... THAT OTHER GARBAGE
MAY, AND I MEAN MAY, KEEP THE LIGHTS ON FOR A BIT... BUT ITS NOT THE BIG DEAL THEY TRY AND
MAKE IT OUT TO BE... SELLING THAT STUFF TO US AS HUGE NEWS IS LIKE A SHADY CAR SALESMAN
AT SOME THIRD RATE CAR DEALERSHIP ON SIDE OF ROAD SELLING US A 2000 HONDA WITH ONLY
85,000 MILES AND “NEVER BEEN IN ACCIDENT” KNOWING ITS COVERED IN BONDO AND THEY ROLLED
BACK THE ODOMETER!!!!
WONDER WHY DR JAVITT FELT IT SO NECESSARY TO POST THAT AND “CORRECT” AND PROVIDE “CLARIFICATION“ TO WHAT PEOPLE ARE SAYING
BUT.....
HE AVOIDS CLARIFYING WHY A NRX AUTHOR (EMPLOYEE) SAID “AVIPTADIL“ HAD EUA APPROVAL IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA...
BEEN ASKED A FEW TIMES “WHATS BETTER STOCK TO OWN HERE”
RELIEFS MANAGEMENT IS TRULY ABYSMAL I MEAN ABSOLUTELY WORTHLESS...
NRX MANAGEMENT IS SLIME, but 1% better AT LEAST YOU CAN TELL THEY CARE ABOUT THEIR COMPANY... I MEAN, THEIR GREED IS GOING TO SINK THIS ALL BUT THEY APPEAR TO CAR.
RAM, JACK, AND THE REST AT RELIEF CAN CARE LESS AS LONG AS THEY ARE RICH
AT THIS POINT OF YOU CAN INVEST IN LITIGATION OR SOMEHOW BET THAT THIS GOES TO COURT DO THAT!!!
YET MORE EVIDENCE THAT RELIEF ATROCIOUS MANAGEMENT TEAM TOP TO BOTTOM CARE ABSOLUTELY NOTHING ABOUT THEIR SHAREHOLDERS!!!! HEY JACK AND RAM... ALL THE ACER AND APR DOESNT MEAN ANYTHING WITHOUT RLF!!! PERIOD... HOW CAN YOU STAT SILENT NOW????? ABYSMAL!! UNTRUSTWORTHY AND DISHONEST TO THE CORE
*** ASK YOURSELF WHY DR JAVITT ......****
WOULD POST SUCH A DIRECT, SHORT, Q&A... MAKES ZERO SENSE ESPECIALLY WHILE SUPPOSEDLY
WAITING ON FDA DECISION!!!! LIKE IVE SAID ALL ALONG BOTH MANAGEMENT TEAMS OF $NRXP AND
$RLFTF ARE SLIME!! CARE ONLY ABOUT $$!!!!
THE PATENT NUMBER THEY LIST IS RELIEFS!!!!
THAT IS AS BLACK AND WHITE AS IT GETS... THEY ARE SAYING RELIEFS PATENT DOES NOT... DOES
NOT, COVER ZYESAMI!!!!
ZYESAMI is not currently covered by any US or international patent. US Patent 8178489B2 and foreign counterparts does not apply to ZYESAMI because it covers only formulations of aviptadil that are formulated in a buffer.
RAM, JACK, AND THE REST OF THE WORTHLESS MANAGEMENT AT RELIEF CANT STAY QUIET ANY LONGER!!!! THE COURTROOM WITH NRX WONT BE THEIR ONLY LITIGATION. !!!!
HEY PENNY... OR....
NRX IS GOING TO SAY RELIEF VIOLATED THE CONTRACT BY NOT PAYING FOR EXPENSES AND/OR
INHALER TRIAL THUS VOIDING THE CONTRACT AND ALL IP LIES SOLEY WITH THEM!!!!
LIKE IVE BEEN SAYING ALL ALONG... INEPT GREEDY MANAGEMENT!!!!!!
**** READ THIS.....****
"A patent is active and covers certain formulations of aviptadil prepared in a buffer." I believe Dr. J said the new formulation is not made in a buffer. So is he saying the new formulation has not patent? And if he is why is he saying it? And making it a point for everyone to see by putting up on the NRX website.
CLEAR AS MUD AS ALWAYS BUT....
TAKING INTO ACCOUNT THE FEUD AND NOW THIS NEW STATEMENT AND ABSOLUTE SILENCE FROM
THE ABYSMAL MANAGEMENT OF RELIEF... GET READY FOR LITIGATION!!!!
UPDATE ON NRX WEBSITE
Q: Who owns the patent to aviptadil?
A: There is no known patent to aviptadil, just like there is no known patent to insulin. A patent is active and covers certain formulations of aviptadil prepared in a buffer. Dr. Sami Said (1928-2013) was issued multiple patents for various uses of Aviptadil which expired around the year 2000.
**** INTERESTING THOUGHT****
MAYBE WE CAN TAKE A PAGE FROM OTHER BIOTECHS AND THEIR RECENT EVENTS TO FINALLY FIND
THE TRUTH.... I KNOW THE FDA HAS RESPONDED IN LETTER FORM BEFORE TO INQUIRIES AS TO
WHY A CERTAIN DRUG HAD NOT BEEN APPROVED... MAYBE WE CAN FIND THE ANSWERS TO THE
QUESTIONS $RLFTF AND $NRXP REFUSE TO ANSWER... SQUEAKY WHEELS
***** FOOD FOR THOUGHT*****
ONE THING THE CYDY FOLKS DID RIGHT IS MAKE ENOUGH NOISE THAT THEY ACTUALLY GOT THE TRUTH SENT TO THEM (albeit a VERY nasty letter). MAYBE THEY WERENT WRONG
IN THEIR APPROACH... AT LEAST THEY STOPPED BEING MISLED!!!!
AT LEAST NOW WE KNOW WHEN THE NEXT “DELAY” ANNOUNCEMENT WILL BE MADE... DURING THE CLINICAL UPDATR PORTION OF “EARNINGS” CALL ON AUG 16th!!!! SO WE CAN PRETTY MUCH BET ON NOTHING HAPPENING BETWEEN NOW AND THEN.... IMAGINE OF THIS AMAZING THERAPEUTIC WAS BEING BROUGHT TO MARKET BY ACTUAL COMPETENT PEOPLE WHO CARED MORE ABOUT THIS THAN THEIR OWN POCKETBOOKS
**** IF ONLY THAT FAST!!!!****
”We look forward to working as quickly as possible with the FDA in hopes of providing critically ill patients with a new medicine that will increase their chances of recovery and survival, enabling them to leave the hospital and return to their families significantly sooner.”
THIS IS AS QUICKLY AS POSSIBLE??
I WISH THEY WOULD HAVE SAID WE WILL WORK AS QUICKLY AS WE DID TO ENSURE OURSELVES AND OUR FAMILIES ARE RICH!!!! ... NOW THATS FAST!!!!!
300% GROWTH JUST TO GET BACK TO WHERE WE WERE ON 2/8 BEFORE THEIR INPET PR ABOUT 28 DATA CRUSHED SHAREHOLDERS.... RAM, JACK, AND THE REST OF THE WORTHLESS MANAGEMENT TEAM AT RELIEF HAVE SHOWN TIME AND TIME AGAIN THAT THEY CARE NOTHING ABOUT SHAREHOLDERS OR IMO THE SICK IN EUROPE AS THEY SIT ON DATA THEY COMPLAINED ABOUT NOT GETTING WAITING FOR FDA DECISION... NOTICE THEY ABSOLUTELY DO NOT WAIT TO GIVE THEMSELVES TWO ROUNDS OF CORPORATE COMPENSATION.... HAS BEEN/NEVER WERE HACKS!!!! A REAL MANAGEMENT TEAM BEHIND THIS AMAZING THERAPEUTIC AND THE WORLD WOULD BE BEGGING FOR IT!!!!
LOOKING FORWARD TO ALOT OF INTERESTING QUESTIONS ANSWERED
YEAH I SEE NO REASON WHY CRAMER CALLED IT A PUMP AND DUMP.... NRX AUTHOR IN PRE PRINT STATES AVIPTADIL EUA APPROVED IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA, RIGHT BEFORE THEY RING BELL AT NASDAQ, THEN SNEAK IN AND CHANGE IT TO “VIP” ”EUA AND/OR COMPASSIONATE CARE IN MANY COUNTRIES”
NO WONDER THE GUY DOING INTRO YESTERDAY JOKED ASKING DR JAVITT IF HE WANTED TO RING THE BELL EARLY AND “LOCK IN GAINS”
WONDER WHAT Thomaz Burckhardt IS UP TO? THAT IS GONNA BE ONE INTERESTING “interview”
DAY 72!!!!
SOME GUIDED MISSLE HUH????
Javitt said the U.S. regulator already “knew a lot about our drug,” and he's expecting a prompt reply. The agency typically responds to emergency use authorization requests within 60 days.
THEY “KNEW SO MUCH” THEY JUST HAD TO ASK FOR MORE INFO... MISLEAD MISLEAD MISLEAD MISLEAD!!!!
STILL NO EXPLANATION ON HOW NRX AUTHOR THOUGHT AVIPTADIL HAD EUA IN UKRAINE, CAUCUS REGION AND INDIA!!! SCARY.. AND THESE ARE THE SAME “EXPERTS” GIVING THE FDA INFO???? FANTASTIC
THE REGULATORY AGENCY THAT “already knows a lot about our drug“, and as such we were MISLED/TOLD (again) to expect “prompt” reply/decision is now at 72 DAYS!!!! Such an AMAZING “DREAM TEAM”... IMAGINE IF THEIR RAISES AND MERGER WERE DELAYED LIKE THIS... oh the humanity, the most important thing to them ($) in their pockets delayed... funny how that didn’t happen!!!! Lack of Honesty and transparency is astounding!! How many times can they say “oops” we misspoke or made a typographical error before it become intentionally misleading? Remember the inhaler trial that was starting in a couple weeks (Oct 2020 interview), or “prompt” review of EUA, or the latest AVIPTADIL HAS EUA IN GEORGIA, UKRAINE, CAUCUS region and INDIA!! FUNNY all these “mistakes” are made with this but not the raise, COMPENSATION OR MERGER PACKAGE
***** HOW MISLEADING IS THIS... SOOOO SHADY****
I JUST REALIZED ANOTHER HUGE CHANGE TO PREPRINT... WHAT A BUNCH OF SHADY SHADY INDIVIDUALS!!!!!!
****NOTICE THEY ALSO CHANGED IT FROM READING AVIPTADIL (WHICH SIGNIFIES OUR DRUG ) TO THE NEW PREPRINT VERBIAGE READS VIP!!!! SOOOOOO MISLEADING!!
NOW THEY CAN SAY THAT INDIA (FOR EXAMPLE APPROVED VIP <NOT AVIPTADIL>) SUCH MISINFORMATION, SOOOOO MISLEADING TO INVESTORS!!!!
JUST LIKE I POSTED EARLIER WHEN I SAID THEY SPECIFICALLY USED TERM ”AVIPTADIL” IN EARLIER PRINT WHICH IS OUR DRUG IN PREVIOUS MISLEADING PRE PRINT... NOW (CYA) CHANGED IT TO VIP!!
MISLEADING PRE PRINT :
“Aviptadil has been granted compassionate care authorization in the United States and Israel and has been granted Emergency Use Authorization in Georgia, Ukraine, and the Caucasus region, as well as India.”
NEW (CYA) PRE PRINT AFTER GETTING CAUGHT:
No drug has been approved for treating respiratory failure in critically ill patients with COVID-19, which remains highly lethal, despite intensive care and currently-approved antiviral and anti-cytokine drugs. Vasoactive Intestinal Peptide (VIP) has been granted Emergency Use Authorization and or Compassionate Care Authorization in multiple countries.”
SOMMERSEBY... THAT IS A DIRECT EFFECT
OF THE ABYSMAL MANAGEMENT OF RELIEF... THEY DO ABSOLUTELY NOTHING TO BUILD PUBLIC
AWARENESS THAT RELIEF IS THE PATENT HOLDER AND HOLDS LION SHARE OF PROFITS.... PEOPLE
ARE INHERENTLY LAZY AND THEY WILL SEE NRX AND ZYESAMI ALL OVER NEWS AND BUILDING
THEIR PUBLIC AWARENESS AND MONIES WILL INVEST THERE... RAM, JACK, AND THE ENTIRE
DISASTROUS MANAGEMENT TEAM WE ARE SADDLED WITH HAVE DONE NOTHING AND CONTINUE TO
DO NOTHING BUT HURT SHAREHOLDERS WHILE MAKIMG SURE THEY ARE RICH!! THEY CARE
NOTHING ABOUT US, AND UNLESS THEY START ACTUALLY EARNING THEIR YET UNDESERVED
PAY/RAISES OUR SP WILL SUFFER AND WE WILL BE SECOND FIDDLE TO NRX
STATING MULTIPLE COUNTRIES APPROVED EUA
IS WAY WAY MORE THAN “GRAMMATICAL ERROR”
JUST HAPPENSTANCE ALSO THAT “MISTAKE” IN PREPRINT DAY BEFORE THE STOCK MAKES RUN HUH!!!! WONDER HOW MANY PEOPLE BOUGHT BASED ON WHAT WAS REPORTED IN PRE PRINT ABOUT EUA APPROVAL IN NOT ONLY GEORGIA BUT UKRAINE, CAUCUS REGION, AND INDIA!!!!!!
AT WHAT POINT WILL THEY BE HELD ACCOUNTABLE FOR MISLEADIMG INVESTORS???? OBVIOUSLY REMOVED UKRAINE, CAUCUS REGION, AND INDIA FROM PRE PRINT WHERE THEY CLAIMED EUA....
SO DID THEY PURPOSELY PUT THAT IN THERE TO MOSLEAD INVESTORS??
IF NOT, HOW DO THEY MAKE THAT MISTAKE? DO THEY HAVE EUA IN THOSE AREAS AND NOT TELLING?
IT IS CONCERNING THAT THESE SAME PEOPLE WHO CONTINUE TO MAKE THESE “MISTAKES” ARE THE SAME ONES PROVIDING US WITH THE DATA/SCIENCE WE PUT OUR MONEY INTO
**** NEW CHANGES TO PRE PRINT****
WHAT AN ABSOLUTE JOKE!!!!!! THEY GET CALLED OUT ON IT AND SNEAK ON LIKE RATS AND CHANGE IT WITH ZERO EXPLANATION!!!
NOTICE ANYTHING DIFFERENT?? check the old page 4!!
https://privpapers.ssrn.com/sol3/papers.cfm?abstract_id=3830051
WE ARE VICTIMS OF HORRENDOUS MANAGEMENT.... RAM, JACK, AND THE REST OF THE ABSOLUTELY WORTHLESS CREW HAVE DONE ABSOLUTELY NOTHING TO REWARD SHAREHOLDERS.... WE STILL HAVE TO GO UP 300% JUST TO MAKE BACK THE LOSSES FROM 2/9 DISASTER!!!! INEPT MANAGEMENT AT ITS FINEST... ENSURED THEY GOT RICH WHILE CRUSHING SHAREHOLDERS..... THEY ARE DISGRACE, NO WONDER THEY ARENT WOTH BP ANYMORE!! HACKS!!!!
ONE GARBAGE WORTHLESS MOVE AFTER THE NEXT!! ACER/APR... WORTHLESS WITHOUT RLF-100
AND THEY REFUSE TO DO ANYTHING TO SEEK APPROVAL IN THEIR AREAS OR ADVANCE AWARENESS!!!!!
THEN WHY PR THE GEORGIA EUA?
WHY MAKE SUCH A BIG DEAL ABOUT THAT EUA ANNOUNCEMENT?
WHY MENTION IT SPECIFICALLY IN PR ABOUT RINGING THE BELL!!
I DO AGREE THAT THE FDA IS THE ABSOLUTE... 100%... PROBLEM IS, ITS DELAY AFTER DELAY...
DR JAVITT STATED THAT THE US REGULATORY BOARD (FDA) ALREADY KNOWS A LOT ABOUT OUR
DRUG AND THAT HE EXPECTS A PROMPT RESPONSE.... WELL GUESS WHAT THEIR RESPONSE WASNT
PROMPT AND THEY ASKED FOR YET MORE INFORMATION FURTHER DELAYS!!!!! WE WERE SOLD
A FALSE BILL OF GOODS OVER AND OVER AND OVER AGAIN... IMO
PENNY.. ITS NOT ABOUT PR’s...
ITS ABOUT MIXED MESSAGES AND MISLEADING INFORMATION.....
DO WE HAVE EUA IN MULTIPLE COUNTRIES AS NRX COAUTHORED PRE PRINT STATES OR IS IT JUST
IN NATION OF GEORGIA.... THATS A HUGE DEAL AND A LEGITIMATE QUESTION!
**** HOW IS IT FUD****
HOW is it FUD....
NRX CO-AUTHORS PRE PRINT THAT SAYS EUA IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA.... YET ISSUES NO PR...
ISSUES PR ABOUT EUA IN GEORGIA AND THEN STATES “CELEBRATING OUR FIRST EUA OVERSEAS”
AND I ASK THE QUESTION WHY THE MIXED MESSAGES YET AGAIN? WHY THE CONSTANT MISINFORMATION, MISLEADING STATEMENTS.. ITS HAPPENED CONTINUALLY OVER THE PAST YEAR... BE IT STATED PRODUCTION NUMBERS ON DR YO THAT CHANGED NUMEROUS TIMES FROM 100,000 TO 30,000 TO NOW BEING TOLD AT THAT TIME IT WAS ONLY PRODUCING 100 DOSES A DAY?!?! HOW IS IT FUD ASKING A LEGITIMATE QUESTION ABOUT STATEMENTS THEY RELEASED!!!!
IS THE PRE PRINT STILL AVAILABLE? (OR REMOVED AGAIN) DID EVERYONE MAKE SURE TO DOWNLOAD IT AND TIME STAMP IT?? EUA APPROVAL IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA HUH???? WHY ARE YOU CELEBRATING YOUR FIRST EUA OVERSEAS??? WHY ARE YOU/WE NOT CELEBRATING THE OTHER ONES? WHY HAVENT YOU PR’d THEM? DO THEY NOT EXIST? SOMETHING DOESNT SEEM RIGHT...
IS THE PRE PRINT STILL AVAILABLE? DID EVERYONE MAKE SURE TO DOWNLOAD IT AND TIME STAMP IT?? EUA APPROVAL IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA HUH???? WHY ARE YOU CELEBRATING YOUR FIRST EUA OVERSEAS??? WHY ARE YOU/WE NOT CELEBRATING THE OTHER ONES? WHY HAVENT YOU PR’d THEM? DO THEY NOT EXIST? SOMETHING DOESNT SEEM RIGHT...
“CELEBRATE OUR FIRST EUA”??????
WAIT WHAT???? WHY THE CONSTANT MISINFORMATION AT WHAT POINT DOES IT BECOME PURPOSELY MISLEADING INVESTORS???? PRE PRINT SAYS EUA APPROVAL IN GEORGIA, UKRAINE, CAUCUS REGION AND INDIA... YET THIS COMMENT TODAY?????? (FIRST GRANT OF EMERGENCY USE??)
As we celebrate our first grant of Emergency Use of ZYESAMI™ for COVID-19 overseas and as we initiate international trials for a novel COVID-19 vaccine, we are honored to ring the Nasdaq closing bell," said Prof Jonathan Javitt, MD, MPH Chairman and CEO of NRx.
*** THIS IS NOT NEW INFO*****
ARE WE TO THE POINT WHERE WE GET EXCITED ABOUT INFO BEING REHASHED??
WE HEARD THIS ALREADY...
RADNOR, Pa., July 22, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has validated the first commercial formulation of ZYESAMI™ (aviptadil) for intravenous use, allowing for high volume manufacture
NOW:
By Gavins Felicity - August 9, 2021
NRx Pharmaceuticals (NASDAQ: NRXP) has announced the validation of the first commercial ZYESAMI (aviptadil) formulation for intravenous use, permitting high volume production.
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/nrx-pharmaceuticals-announces-first-successful-104800474.html